EPISODE · Feb 13, 2026 · 1 MIN
The first patient enrolled in the Phase II/III clinical trial of the new TYKtwo inhibitor
from DTnewswire · host DTnewswire
Smf5Yv7iSAZW7lGwgunC
Embed this episode
Ready to play
The first patient enrolled in the Phase II/III clinical trial of the new TYKtwo inhibitor
0:00
1:50
1×
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.
Frequently Asked Questions
How long is this episode of DTnewswire?
This episode is 1 minute long.
When was this DTnewswire episode published?
This episode was published on February 13, 2026.
Can I download this DTnewswire episode?
Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!